Healthcare -
Biotechnology - NASDAQ - US
$ 39.1
-10.6 %
$ 239 M
Market Cap
-9.44
P/E
MNPR - REVENUE
Revenue MNPR - Monopar Therapeutics Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR